Apollo + Lpath Sign Merger Agreement

Palo Alto – September 13, 2016 – Cooley advised Apollo Endosurgery on its merger agreement with Lpath. The Apollo security holders are expected to own approximately 95.8 percent of the combined company and the Lpath security holders are expected to own approximately 4.2 percent of the combined company, subject to adjustments as described in the merger agreement. The deal is expected to close in the fourth quarter.

Apollo is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Press Coverage

"VC-backed Apollo Endosurgery and Lpath to Merge," PEHub 

Related Contacts
Mark Weeks Partner, Palo Alto
Mark Windfeld-Hansen Partner, Palo Alto
Michael Tollini Partner, Washington, DC
Barbara Mirza Partner, Los Angeles
Renee Deming Retired Partner, Palo Alto
James Linfield Partner, Colorado
John McKenna Partner, Palo Alto
Josh Seidenfeld Partner, Palo Alto
Sepideh Mousakhani Associate, Palo Alto
Karen Ubell Special Counsel, Palo Alto
Amanda Pacheco Associate, Palo Alto